Skip to content

Common Stock at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%
Savara logo
SavaraSVRA
$204K+17.9%
LQD
Liquidia CorporationLQDA
$88K+3.5%
United Therapeutics logo
United TherapeuticsUTHR
$800K0.0%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$20.81M-26.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6K+20.0%

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's common stock?
Pulmonx Corporation (LUNG) reported common stock of 200M in Q1 2026.
How has Pulmonx Corporation's common stock changed year-over-year?
Pulmonx Corporation's common stock decreased by 0.0% year-over-year, from 200M to 200M.
What is the long-term trend for Pulmonx Corporation's common stock?
Over 5 years (2020 to 2025), Pulmonx Corporation's common stock has grown at a 461.0% compound annual growth rate (CAGR), from 36K to 200M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).